Literature DB >> 18083641

Simultaneous determination of ginsenoside Rg1, Re, Rd, Rb1 and ophiopogonin D in rat plasma by liquid chromatography/electrospray ionization mass spectrometric method and its application to pharmacokinetic study of 'SHENMAI' injection.

Chunhua Xia1, Guangji Wang, Jianguo Sun, Haiping Hao, Yuqing Xiong, Shenghua Gu, Lili Shang, Chaonan Zheng.   

Abstract

A sensitive and rapid liquid chromatography-mass spectrometric method for the simultaneous determination of ginsenoside Rg1, Re, Rd, Rb1 and ophiopogonin D in rat plasma was developed and validated. Chromatographic separation was performed on a C18 column using a step gradient program with the mobile phase of 0.5mmol/L ammonium chloride solution and acetonitrile. The analytes and I.S. were detected using an electrospray negative ionization mass spectrometry in the selected ion monitoring (SIM) mode. The method was linear over the investigated concentration range with a good correlation coefficient higher than 0.997. The lower limits of detection (LLOD) of these analytes were all lower than 2.0ng/mL. The intra- and inter-day precisions were all no more than 7.5% and accuracies were within the range of 97.5-107.0%. The validated method was successfully applied to investigate the pharmacokinetics of ginsenoside Rg1, Re, Rd, Rb1 and ophiopogonin D in rat after intravenous administration of 'SHENMAI' injection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083641     DOI: 10.1016/j.jchromb.2007.11.020

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  8 in total

1.  Ginsenoside Re: Its chemistry, metabolism and pharmacokinetics.

Authors:  Dacheng Peng; Huashan Wang; Chenling Qu; Laihua Xie; Sheila M Wicks; Jingtian Xie
Journal:  Chin Med       Date:  2012-02-07       Impact factor: 5.455

2.  Ophiopogon Polysaccharide Promotes the In Vitro Metabolism of Ophiopogonins by Human Gut Microbiota.

Authors:  Huai-You Wang; Shu-Chen Guo; Zhi-Tian Peng; Cheng Wang; Ran Duan; Tina T X Dong; Karl W K Tsim
Journal:  Molecules       Date:  2019-08-08       Impact factor: 4.411

3.  The Inhibition Effects of Shenmai Injection on Acetylcholine-Induced Catecholamine Synthesis and Secretion by Modulating Nicotinic Acetylcholine Receptor Ion Channels in Cultured Bovine Adrenal Medullary Cells.

Authors:  Xiting Zhang; Lin Li; Yi Wang; Haoping Mao; Lijuan Chai; Lin Miao; Shuang Wang; Xiumei Gao; Han Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-15       Impact factor: 2.629

Review 4.  Pharmacological Properties of Ginsenoside Re.

Authors:  Xiao-Yan Gao; Guan-Cheng Liu; Jian-Xiu Zhang; Ling-He Wang; Chang Xu; Zi-An Yan; Ao Wang; Yi-Fei Su; Jung-Joon Lee; Guang-Chun Piao; Hai-Dan Yuan
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

5.  Anti-Inflammatory Effects and Molecular Mechanisms of Shenmai Injection in Treating Acute Pancreatitis: Network Pharmacology Analysis and Experimental Verification.

Authors:  Yanqiu He; Cheng Hu; Shiyu Liu; Mingjie Xu; Ge Liang; Dan Du; Tingting Liu; Fei Cai; Zhiyao Chen; Qingyuan Tan; Lihui Deng; Qing Xia
Journal:  Drug Des Devel Ther       Date:  2022-08-02       Impact factor: 4.319

Review 6.  An overview of systematic reviews of shenmai injection for healthcare.

Authors:  Ling-Yan Lu; Guo-Qing Zheng; Yan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-12       Impact factor: 2.629

7.  Ginsenoside Rb1 and Rd Remarkably Inhibited the Hepatic Uptake of Ophiopogonin D in Shenmai Injection Mediated by OATPs/oatps.

Authors:  Xiaopei Liu; Lin Chen; Mingyi Liu; Hong Zhang; Shibo Huang; Yuqing Xiong; Chunhua Xia
Journal:  Front Pharmacol       Date:  2018-08-22       Impact factor: 5.810

8.  Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial.

Authors:  Yushu Zhou; Baiming Zhao; Wanyin Wu; Xiaobing Yang; Shunqin Long; Hong Deng; Wenfeng He; Guiya Liao; Qiuping Li; Zhen Xie
Journal:  Trials       Date:  2018-09-04       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.